Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
International Flavors & Fragrances
IFF
|
+$159M |
| 2 |
Broadcom
AVGO
|
+$140M |
| 3 |
Builders FirstSource
BLDR
|
+$128M |
| 4 |
Equinix
EQIX
|
+$98.7M |
| 5 |
ConocoPhillips
COP
|
+$89.1M |
Top Sells
| 1 |
GameStop
GME
|
+$746M |
| 2 |
Chevron
CVX
|
+$276M |
| 3 |
Apple
AAPL
|
+$238M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
+$178M |
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.68% |
| 3 | Industrials | 13.56% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Vale
VALE
$45.4B
| $14.2M | ﹤0.01% |
818,905
| – | – |
|
2177
Regis Corp
RGS
$66.7M
| $14.2M | ﹤0.01% |
56,357
-20,777
| -27% | -$5.22M |
|
2178
Clearfield
CLFD
$456M
| $14.1M | ﹤0.01% |
469,501
-7,805
| -2% | -$235K |
|
|
CSR
2179
Centerspace
CSR
$972M
| $14.1M | ﹤0.01% |
207,967
-5,422
| -3% | -$369K |
|
2180
AnaptysBio
ANAB
$637M
| $14.1M | ﹤0.01% |
655,712
+69,160
| +12% | +$1.49M |
|
2181
Arrowhead Research
ARWR
$3.99B
| $14.1M | ﹤0.01% |
213,076
-19,224
| -8% | -$1.27M |
|
|
CAMP
2182
DELISTED
CalAmp Corp.
CAMP
| $14.1M | ﹤0.01% |
56,576
-6,911
| -11% | -$1.72M |
|
2183
Bally's
BALY
$487M
| $14.1M | ﹤0.01% |
216,703
+67,632
| +45% | +$4.4M |
|
2184
RB Global
RBA
$22B
| $14M | ﹤0.01% |
239,227
+57,321
| +32% | +$3.36M |
|
2185
Orion Group Holdings
ORN
$295M
| $13.9M | ﹤0.01% |
2,292,514
+32,855
| +1% | +$199K |
|
2186
Sanofi
SNY
$116B
| $13.9M | ﹤0.01% |
281,301
| – | – |
|
2187
Tidewater
TDW
$2.97B
| $13.9M | ﹤0.01% |
1,108,082
+24,661
| +2% | +$309K |
|
|
TA
2188
DELISTED
TravelCenters of America LLC
TA
| $13.9M | ﹤0.01% |
511,624
-13,323
| -3% | -$361K |
|
2189
Collegium Pharmaceutical
COLL
$1.19B
| $13.8M | ﹤0.01% |
582,440
-22,094
| -4% | -$525K |
|
2190
Genco Shipping & Trading
GNK
$763M
| $13.8M | ﹤0.01% |
1,366,514
-34,610
| -2% | -$349K |
|
2191
Greenlight Captial
GLRE
$424M
| $13.8M | ﹤0.01% |
1,578,335
-135,238
| -8% | -$1.18M |
|
2192
ING
ING
$73.9B
| $13.8M | ﹤0.01% |
1,125,380
-541,092
| -32% | -$6.62M |
|
2193
Phibro Animal Health
PAHC
$1.67B
| $13.8M | ﹤0.01% |
563,991
+3,352
| +0.6% | +$81.8K |
|
2194
Adverum Biotechnologies
ADVM
$69.5M
| $13.8M | ﹤0.01% |
139,844
-31,130
| -18% | -$3.06M |
|
|
AMNB
2195
DELISTED
American National Bankshares Inc
AMNB
| $13.8M | ﹤0.01% |
415,986
+1,581
| +0.4% | +$52.3K |
|
2196
Elastic
ESTC
$9.46B
| $13.7M | ﹤0.01% |
123,578
-2,243
| -2% | -$249K |
|
2197
Ardelyx
ARDX
$1.6B
| $13.7M | ﹤0.01% |
2,070,375
+209,819
| +11% | +$1.39M |
|
2198
Magnachip Semiconductor
MX
$110M
| $13.7M | ﹤0.01% |
550,563
+1,430
| +0.3% | +$35.6K |
|
|
EGRX
2199
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $13.7M | ﹤0.01% |
327,907
+20,897
| +7% | +$872K |
|
2200
Old Second Bancorp
OSBC
$963M
| $13.7M | ﹤0.01% |
1,035,553
-32,645
| -3% | -$431K |
|